This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Julius Ndirangu Mugweru
Introduction
Julius Ndirangu Mugweru is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tuberculosis. His innovative work has led to the development of a unique method that addresses critical health challenges.
Latest Patents
Julius holds a patent for the "Construction Method of Recombinant Drug-Resistant Mycobacterium Bovis Bacillus Calmette-Guerin (BCG) Strain and Pharmaceutical Composition for Treating Tuberculosis (TB)." This patent represents a significant advancement in the fight against tuberculosis, showcasing his commitment to improving public health.
Career Highlights
He is affiliated with the Chinese Academy of Sciences, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a focus on creating effective treatments that can combat drug-resistant strains of diseases.
Collaborations
Julius has collaborated with esteemed colleagues such as Tianyu Zhang and Bangxing Wang. These partnerships have enhanced his research efforts and contributed to the successful development of his patented innovations.
Conclusion
Julius Ndirangu Mugweru's contributions to the field of medicine through his innovative patents highlight his dedication to addressing global health issues. His work continues to inspire advancements in tuberculosis treatment and showcases the importance of research and collaboration in the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile